LIFEMD INC (LFMD) Stock Fundamental Analysis
NASDAQ:LFMD - Nasdaq - US53216B1044 - Common Stock - Currency: USD
LFMD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. LFMD may be in some trouble as it scores bad on both profitability and health. LFMD is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
LFMD had negative earnings in the past year.
In the past year LFMD had a positive cash flow from operations.
In the past 5 years LFMD always reported negative net income.
In multiple years LFMD reported negative operating cash flow during the last 5 years.
1.2 Ratios
LFMD's Return On Assets of -12.28% is in line compared to the rest of the industry. LFMD outperforms 57.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With an excellent Gross Margin value of 87.57%, LFMD belongs to the best of the industry, outperforming 94.29% of the companies in the same industry.
LFMD's Gross Margin has improved in the last couple of years.
LFMD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
2. Health
2.1 Basic Checks
LFMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LFMD has more shares outstanding
The number of shares outstanding for LFMD has been increased compared to 5 years ago.
LFMD has a better debt/assets ratio than last year.
2.2 Solvency
Based on the Altman-Z score of 0.86, we must say that LFMD is in the distress zone and has some risk of bankruptcy.
LFMD's Altman-Z score of 0.86 is in line compared to the rest of the industry. LFMD outperforms 48.57% of its industry peers.
LFMD has a debt to FCF ratio of 2.31. This is a good value and a sign of high solvency as LFMD would need 2.31 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.31, LFMD is in the better half of the industry, outperforming 74.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Altman-Z | 0.86 |
ROIC/WACCN/A
WACC10.91%
2.3 Liquidity
A Current Ratio of 0.77 indicates that LFMD may have some problems paying its short term obligations.
The Current ratio of LFMD (0.77) is worse than 82.86% of its industry peers.
LFMD has a Quick Ratio of 0.77. This is a bad value and indicates that LFMD is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.72, LFMD is doing worse than 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 70.00% over the past year.
Looking at the last year, LFMD shows a very strong growth in Revenue. The Revenue has grown by 37.74%.
LFMD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 76.23% yearly.
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
3.2 Future
LFMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.78% yearly.
LFMD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 26.03% yearly.
EPS Next Y103.4%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue Next Year31.46%
Revenue Next 2Y24.78%
Revenue Next 3Y26.03%
Revenue Next 5YN/A
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
LFMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 20.06, which indicates a rather expensive current valuation of LFMD.
LFMD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LFMD is cheaper than 80.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LFMD to the average of the S&P500 Index (35.31), we can say LFMD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.06 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, LFMD is valued a bit cheaper than the industry average as 68.57% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, LFMD is valued a bit cheaper than 65.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 44.77 | ||
| EV/EBITDA | 32.65 |
4.3 Compensation for Growth
LFMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LFMD's earnings are expected to grow with 41.78% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y61.53%
EPS Next 3Y41.78%
5. Dividend
5.1 Amount
No dividends for LFMD!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.6
-0.29 (-4.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners37.54%
Inst Owner Change0.8%
Ins Owners17.39%
Ins Owner Change4.81%
Market Cap299.97M
Analysts81.33
Price Target14.28 (116.36%)
Short Float %11.55%
Short Ratio2.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-34.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-258.37%
Min EPS beat(2)-635.29%
Max EPS beat(2)118.55%
EPS beat(4)2
Avg EPS beat(4)-117.63%
Min EPS beat(4)-635.29%
Max EPS beat(4)118.55%
EPS beat(8)3
Avg EPS beat(8)-68.88%
EPS beat(12)5
Avg EPS beat(12)-64.04%
EPS beat(16)6
Avg EPS beat(16)-52.91%
Revenue beat(2)1
Avg Revenue beat(2)-2.54%
Min Revenue beat(2)-8.06%
Max Revenue beat(2)2.97%
Revenue beat(4)2
Avg Revenue beat(4)0.5%
Min Revenue beat(4)-8.06%
Max Revenue beat(4)9.78%
Revenue beat(8)5
Avg Revenue beat(8)1.81%
Revenue beat(12)7
Avg Revenue beat(12)-0.1%
Revenue beat(16)7
Avg Revenue beat(16)-1.47%
PT rev (1m)7.69%
PT rev (3m)16.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)70.52%
EPS NY rev (1m)0%
EPS NY rev (3m)132.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.17%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.09%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 20.06 | ||
| P/S | 1.22 | ||
| P/FCF | 44.77 | ||
| P/OCF | 15.4 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 32.65 |
EPS(TTM)-0.21
EYN/A
EPS(NY)0.33
Fwd EY4.98%
FCF(TTM)0.15
FCFY2.23%
OCF(TTM)0.43
OCFY6.49%
SpS5.4
BVpS-0.04
TBVpS-0.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -12.28% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 87.57% | ||
| FCFM | 2.73% |
ROA(3y)-86.73%
ROA(5y)-171.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.22%
GM growth 5Y3.8%
F-Score5
Asset Turnover3.34
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 2.31 | ||
| Debt/EBITDA | 0.41 | ||
| Cap/Depr | 120.74% | ||
| Cap/Sales | 5.2% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 227.76% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.77 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 0.86 |
F-Score5
WACC10.91%
ROIC/WACCN/A
Cap/Depr(3y)162.46%
Cap/Depr(5y)195.18%
Cap/Sales(3y)6.18%
Cap/Sales(5y)4.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68.42%
EPS Next Y103.4%
EPS Next 2Y61.53%
EPS Next 3Y41.78%
EPS Next 5YN/A
Revenue 1Y (TTM)37.74%
Revenue growth 3Y31.75%
Revenue growth 5Y76.23%
Sales Q2Q%22.81%
Revenue Next Year31.46%
Revenue Next 2Y24.78%
Revenue Next 3Y26.03%
Revenue Next 5YN/A
EBIT growth 1Y89.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year279.84%
EBIT Next 3Y73.97%
EBIT Next 5YN/A
FCF growth 1Y162.68%
FCF growth 3YN/A
FCF growth 5Y88.7%
OCF growth 1Y816.14%
OCF growth 3YN/A
OCF growth 5Y133.93%